• Profile
Close

Assessment of clinical efficacy of lidocaine/tetracaine 7%/7% peel cream in fractional micro-ablative laser procedure-associated pain for facial skin ageing treatment. A randomized, controlled, single-blind trial

Journal of Cosmetic Dermatology Jun 19, 2021

Caprari E, et al. - Since lidocaine/tetracaine 7%/7% peel cream (L/T-pC) is very effective in reducing pain in several dermatological procedures like hair or tattoo laser removal or conventional photodynamic therapy associated pain, researchers performed a prospective, randomized, parallel-group, controlled, single-blind trial to evaluate the clinical effectiveness of L/T-pC in reducing pain during microablative fractional laser resurfacing treatment in individuals with facial skin ageing. In total, 30 individuals (4 men, 26 women; mean age 42 ± 10 years; range 28-57) with mild to moderate facial skin ageing (Glogau score ≥ 2), suitable for FLR treatment, were recruited after their written informed consent. Study participants were randomly assigned to either the L/T-pC application (45 minutes before the laser treatment with the removal of the cream just before the starting of laser session) (n = 20) or to control (emollient cream; n = 10). The use of L/T pC 7%/7% peel cream prior to a fractional laser resurfacing session significantly reduced procedure-associated pain while maintaining high tolerability and safety profile.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay